ICD/Pacer Advisory Standards Should Be Developed – FDA Panel Chair
This article was originally published in The Gray Sheet
Executive Summary
Publicity surrounding recent ICD defects will spur the the Heart Rhythm Society to develop guidelines on manufacturers' advisories to physicians, FDA's Circulatory System Devices Panel chair says
You may also be interested in...
Fracture Data Spurs Medtronic To Suspend Sales Of Fidelis ICD Lead
Medtronic's decision to halt worldwide distribution of its Sprint Fidelis defibrillator leads has attracted congressional scrutiny of the company's response to data showing the leads were vulnerable to fracture
Fracture Data Spurs Medtronic To Suspend Sales Of Fidelis ICD Lead
Medtronic's decision to halt worldwide distribution of its Sprint Fidelis defibrillator leads has attracted congressional scrutiny of the company's response to data showing the leads were vulnerable to fracture
Boston Scientific Settles With States On Guidant ICD Investigations
Boston Scientific agreed Aug. 30 to pay $16.75 million to 35 states and the District of Columbia to settle investigations into the lack of public disclosure of certain defibrillator risks